Executive Interview : Q&A with Dr.A. Sankaranarayanan, CEO on Drug Discovery and India

Submitted by on Mon, 01/04/2010 - 22:24

Exclusive Interview with A. Sankaranarayanan, Ph.D., F.C.P.,Director & CEO, Vivo Bio Tech Ltd. (http://www.vivobio.com/) .



Key Points discussed about

Trends and challenges in new drug discovery programs in India

  • Drug discovery research and development in India
  • Challenges facing by the Pharmaceutical industries in India
  • R&D in the pharma industry
  • Challenges from Government of India
  • Need for collaboration of Indian Pharmaceutical Industries and Pharmaceutical Education Institutes
  • Challenges of innovative R&D-driven enterprises
  • Need of technocrats in Government of India
  • Future of India's pharma industry in new drug discovery


    • About Dr.Sankaranarayanan

    Dr. Alangudi Sankaranarayanan, is a Discovery Scientist with more than 35 years of experience in Pharmaceutical R&D. He has a unique blend of scientific & management experience in Drug Discovery and Development. Having originally started in Veterinary Science, he moved onto Clinical Pharmacology and later into Drug Discovery.He has patented several molecules in the area of cardiovascular & metabolic disorders. He is an excellent mentor and team builder having guided about 20 Research theses and presenting research papers in about 80 scientific conferences. His scientific contributions have resulted in over 70 publications including PNAS & is an avid key persona in academic research and training. He has taught at PGIMER, Chandigarh & BITS affiliate programs.

    He has membership in several scientific societies such as Fellow of American College of Clinical Pharmacology, American Society of Pharmacology & Experimental Therapeutics(ASPET), Indian Pharmacological Society, Indian Society for Clinical Pharmacology & Therapeutics, Indian Society for Medical Statistics & Society of Toxicology.